Skip to main content

 The 12 topics addressed by the Belgium 1+MG Mirror Group are listed below and the primary scope is indicated between brackets:

Maturity model 

Maturity model to guide the implementation / Sustainability recommendations/Access to data for research (policy-support, lab-technical, clinical, population-health, ICT, ethics-legal, economics/finance). 

Participants:

Hélène Antoine-Poirel, Belgian Cancer Registry, BCR, Brussels

Miikka Vikkula, Catholic University Louvain (UCLouvain) / de Duve Institute, Leuven

Roberto Salgado, GZA-ZNA Hospitals, Antwerp

Ethical, Legal, and Societal Issues (ELSI)

Ethical, Legal, and Societal Issues (ELSI) - Minimum recommendation on ELSI and data protection (policy-support, ethics-legal) 

Participants:

Romain Alderweireldt, Fondation 101 Génomes, Brussels

Pascal Borry, The Catholic University of Leuven ( KU Leuven), Leuven

Jean-Marc Van Gyseghem, University of Namur / Research Centre Information Law and Society, Namur

Wannes Van Hoof, Sciensano, Brussels

Clinical and phenotypic data

Clinical and phenotypic data requirements / development of standards for clinical interpretation (lab-technical, clinical, population-health)*

Participants:

Valérie Benoit,  Institute of Pathology and Genetics (IPG), Charleroi

François Dufrasne, Université de Mons (UMONS), Mons

Katrien Janssens, Center of Medical Genetics Antwerp, Antwerp

Bart Loeys, Antwerp University Hospital, Antwerp

Yves Sznajer, Cliniques universitaires Saint-Luc, Brussels

Miikka Vikkula, Catholic University Louvain (UCLouvain) / de Duve Institute, Leuven

Wim Wuyts, Antwerp University Hospital / Department of medical genetics, Antwerp

Good sequencing practice / standards on data quality

Good sequencing practice / Minimum standards on data quality and analysis plus data challenges (lab-technical, clinical, population-health, ICT)*

Participants:

François Dufrasne, Université de Mons (UMONS), Mons

Pierrick Moreau, Institute of Pathology and Genetics (IPG), Charleroi

Arvid Suls, The University of Antwerp (UAntwerp), Antwerp

Sonia Van Dooren, University Hospital Brussels (UZ Brussel), Brussels & Vrije Universiteit Brussel (VUB), Brussels

Kevin Vanneste, Sciensano, Brussels

Frederic Vauthier, Institute of Pathology and Genetics (IPG), Charleroi

Joris Vermeesch, The Catholic University of Leuven ( KU Leuven), Leuven

ICT

Federated secure, interoperable framework (lab-technical, clinical, population-health, ICT)

Participants:

Jos Bellens, University Hospital Brussels (UZ Brussel), Brussels

Frederik Coppens, ELIXIR, Ghent

Catharina Olsen, University Hospital Brussels (UZ Brussel), Brussels

Erika Souche, UZ Leuven, Leuven

Geert Vandeweyer, The University of Antwerp (UAntwerp), Antwerp

Health economics

Health economics and outcome research/ Economic models (policy-support, clinical, population-health, ethics-legal, economics/finance)*

Pieter-Jan Stiers

Stakeholders

Stakeholders outreach (policy-support, lab-technical, clinical, population-health, ICT, ethics-legal, economics/finance)

Participant:

Romain Alderweireldt, Fondation 101 Génomes, Brussels

Gert Matthijs, The Catholic University of Leuven ( KU Leuven), Leuven

Case : Rare Diseases

Use case - Rare diseases (lab-technical, clinical, population-health, ethics-legal)*

Participants:

Romain Alderweireldt, Fondation 101 Génomes, Brussels

Karen Colaert, Vlaams agentschap Zorg en Gezondheid (ZG), Brussels

Karin Dahan, Institute of Pathology and Genetics (IPG), Charleroi

Elfride De Baere, Ghent University & Ghent University Hospital (UZ Gent), Ghent

Charlotte De Vogelaere, Sciensano, Brussels

François Dufrasne, Université de Mons (UMONS), Mons

Bart Loeys, Antwerp University Hospital, Antwerp

Frank Kooy, The University of Antwerp (UAntwerp), Antwerp

Geert Mortier, Antwerp University Hospital, Antwerp

Emile Van Schaftingen, Catholic University Louvain (UCLouvain), Leuven

Miikka Vikkula, Catholic University Louvain (UCLouvain) / de Duve Institute, Leuven

Case : Cancer

Use case : Cancer (lab-technical, clinical, population-health, ethics-legal)*

Participants:

Hélène Antoine-Poirel, Belgian Cancer Registry, BCR, Brussels

Vincent Brours, University of Liege, Liege

Jurgen Del Favero, Histogenex, Antwerp

Thomas Delcourt, Sciensano, Brussels

Christine Desmedt, The Catholic University of Leuven ( KU Leuven), Leuven

Barbara Dewaele, University Hospital Leuven (UZ Leuven), Leuven

Ann Gils, Stand up to Cancer (Kom op Tegen Kanker), Brussels

Olga Kholmanskikh, Federal Agency for Medicines and Health Products (FAMHP), Brussels

Brigitte Maes, Jessa Hospital, Hasselt

Case : Personalised prevention/population based sequencing

Use case : Personalised prevention/population based sequencing/genetic variation, pharmacogenomics and common and complex diseases (lab-technical, clinical, population-health, ethics-legal)*

Participants:

Charlotte De Vogelaere, Sciensano, Brussels

Gokhan Ertaylan, VITO, Mol

Michel Georges, University of Liege, Liege

Lies Lahousse, Ghent University, Ghent

Csilla Sipeky, UCB, Brussels

Rosa Rademakers, VIB & University of Antwerp (UAntwerp), Antwerp

Freya Vaeyens, University Hospital Brussels (UZ Brussel), Brussels

Kristel Van Steen, University of Liege, Liege

Case : Covid

Use case : Covid (lab-technical, clinical, population-health, ethics-legal)*

Participants:

Lize Cuypers , University Hospital Leuven (UZ Leuven), Leuven

Thomas Delcourt, Sciensano, Brussels

François Dufrasne, Université de Mons (UMONS), Mons

Sofieke Klamer, Sciensano, Brussels

Marie Lesenfants, Sciensano, Brussels

 

Do you want to join the project as an expert?

Fill the online form here!